Found 4 matching trials
Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS) PHASE2 Myelodysplastic syndromes are common blood disorders that can affect as man...
Show More Location
Odette Cancer Centre, Sunnybrook Health Sciences Centre
Learn More & Join Trial
A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS PHASE1 Determinate safety and response rate of the association Deferasirox -Vitami...
Show More Learn More & Join Trial
Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65 PHASE2 The purpose of this study is to find out if by giving a combination of 3 dr...
Show More Location
Loyola University Cardinal Bernardin Cancer Center
Learn More & Join Trial
Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. PHASE2 The primary objective of the study is to compare the overall response rate ...
Show More Location
Hematology Oncology Services of Arkansas HOSA 2
Learn More & Join Trial